HO
Werewolf Therapeutics, Inc.
HOWL · NASDAQ
$0.93 +0.20% (+$0.00)
1M -5.10%
Market Cap $45.2M
P/E Ratio -
Div. Yield -
ROE 166.99%
Bulios Fair Price
$1.39
49.5% upside
Current Price
$0.93
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HOWL is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
71 /100
Cheap P/S 2.15x
P/B 2.77x
P/E N/A
Growth
0 /100
Declining Book val. growth 41.25%
EPS growth N/A
Rev. growth N/A
Profitability
20 /100
Weak Gross margin 86.43%
Net margin 164.82%
Op. margin 121.78%
Quality
11 /100
Poor ROIC 156.97%
ROE 166.99%
ROA 143.30%
Debt
69 /100
Low Debt/Equity 0.00x
Current ratio 2.91x
Int. coverage -5.64x
Stability
17 /100
Unstable Beta 0.29x
Rev. volatility 67.64%
EPS volatility 51.34%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HOWL
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Daniel J. Hicklin
Employees
39
Headquarters
Watertown
Upcoming events
03 NOV
Earnings
Upcoming earnings report